Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
Launched by HOSPICES CIVILS DE LYON · Aug 18, 2023
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The JUMP Research II trial is studying how cancer affects muscle health in patients who have finished treatment. Researchers want to understand the connection between the strength of the quadriceps muscles (the large muscles at the front of the thigh) and overall muscle health in cancer survivors. They will use ultrasound to check muscle size and strength, which can help identify a condition called sarcopenia, where muscles lose mass and strength. This information is important because many cancer survivors face challenges like muscle weakness, which can affect their recovery and quality of life.
To participate in this trial, individuals need to be between 18 and 74 years old and have had specific types of cancer, such as breast, lung, or colon cancer. They should also have completed a post-cancer assessment day. However, people with active cancer, pregnant women, and those with certain cognitive challenges or language barriers will not be eligible. Participants will have their muscle health evaluated and may receive referrals to programs that can help them improve their physical activity and overall well-being after cancer treatment. This trial aims to improve care for cancer survivors and help them lead healthier lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age : 18 to 74 years
- • localization of the primitive: breast, lung, melanoma, testicle, bladder, kidney, ovary, colon and pancreas, hemopathy
- • patient who benefited from the post-cancer assessment day
- Exclusion Criteria:
- • Active cancer (relapse or new cancer)
- • Pregnant or breastfeeding women
- • Major cognitive impairment making comprehension and exercise difficult
- • Amputation of both lower limbs (for ultrasound)
- • Difficulty understanding oral and written French
- • Adults under legal protection (guardianship, curatorship or safeguard of justice)
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pierre Bénite, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported